elderly all advances: inotuzumab ozogamicin plus mini-hyper-cvd
Published 6 years ago • 101 plays • Length 2:13Download video MP4
Download video MP3
Similar videos
-
4:06
inotuzumab ozogamicin for the treatment of elderly acute lymphoblastic leukemia
-
2:08
inotuzumab ozogamicin & venetoclax in the treatment of b-all: findings from a phase i trial
-
1:37
phase ii trial of inotuzumab ozogamicin to treat mrd b-all
-
3:29
is inotuzumab ozogamicin with low-dose chemotherapy effective in treating all in elderly patients?
-
4:44
emerging novel approaches for all: inotuzumab ozogamicin
-
3:03
novel all treatment strategies: inotuzumab ozogamicin
-
1:13
phase ii study of inotuzumab ozogamicin in mrd b-all
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
16:11
esmo 2024 - daejin abidoye
-
4:44
7-year update on a phase ii trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for cll
-
4:48
the evolution of allosct in richter's transformation and its combination with biological agents
-
1:20
the evolving role of inotuzumab ozogamicin in the treatment of pediatric & older patients with all
-
3:28
inotuzumab as a potential treatment for elderly patients with all
-
1:09
the future of inotuzumab therapy for all
-
1:03
updated results of hyper-cvad and blinatumomab /- inotuzumab ozogamicin in newly-diagnosed b-all
-
2:44
phase ii trial of obinutuzumab, alone and combined with vemurafenib, in r/r hairy cell leukemia
-
2:35
ino-vate: improving all outcomes with inotuzumab
-
1:46
inotuzumab-containing bridging therapy in patients with r/r b-all receiving obe-cel
-
4:44
safety and efficacy of blinatumomab and inotuzumab ozogamicin in multiple relapsed all
-
2:01
elotuzumab and imids in patients with r/r al amyloidosis with advanced organ involvement
-
1:22
all: recent immunotherapeutic developments
-
1:06
the importance of early intervention in myelofibrosis